CAH Cardinal Health

company

SEC Filings & Insider Trading Activity 2026

Risk Factors

• • Legal risk: Potential exposure from product liability and self-insurance accruals noted in loss contingencies, specifics not quantified but integral to financial estimates
• • Geopolitical exposure: GMPD segment manufacturing facilities in 12 countries including Germany, Japan, Malaysia, Mexico, and Costa Rica, subject to international operational risks
• • Operational vulnerability: Inventories increased to $16.8B in 2025 from $15.0B in 2024, indicating susceptibility to supply chain disruptions affecting working capital
• • Competitive risk: Goodwill impairment testing required for Navista & ION and Cardinal Health at-Home Solutions reporting units shows sensitivity to revenue growth and market conditions
• • Financial risk: Long-term obligations rose to $8.0B in 2025 from $4.7B in 2024, increasing leverage and interest expense to $215M, up from $51M prior year

What are the latest CAH SEC filings in 2026?

Cardinal Health (CAH) has filed a 10-K annual report on August 12, 2025, a 10-Q quarterly report on April 30, 2026, an 8-K current report on August 5, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did CAH file its most recent 10-K annual report?

Cardinal Health (CAH) filed its most recent 10-K annual report on August 12, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view CAH 10-Q quarterly reports?

Cardinal Health (CAH)'s most recent 10-Q quarterly report was filed on April 30, 2026. SignalX displays every CAH 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has CAH filed recently?

Cardinal Health (CAH)'s most recent 8-K was filed on August 5, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find CAH insider trading activity (Form 4)?

SignalX aggregates every CAH Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does CAH file with the SEC?

Cardinal Health (CAH) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CAH filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Cardinal Health (CAH).

What is CAH's SEC CIK number?

Cardinal Health (CAH)'s SEC CIK (Central Index Key) number is 721371. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 721371 to look up all CAH filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find CAH return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Cardinal Health (CAH) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.